针刺联合散偏汤治疗偏头痛临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R246.6;R277.7

基金项目:

台州市黄岩区科技项目(2020052)


Clinical Study on Acupuncture Combined with Sanpian Decoction for Migraine
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察针刺联合散偏汤治疗偏头痛的临床疗效。方法:选取108 例偏头痛患者为研究对象, 按随机数字表法分为对照组及试验组各54 例,其中对照组脱落2 例,试验组脱落3 例,最终实际纳入对照组 52 例,试验组51 例。对照组给予氟桂利嗪胶囊治疗,试验组给予针刺联合散偏汤治疗,2 组均治疗4 周。 观察2 组临床疗效及不良反应发生情况,比较2 组复发率,比较2 组治疗前后头痛发作频率、头痛平均持续 时间、疼痛视觉模拟评分法(VAS)、中医证候评分、血清5-羟色胺(5-HT)、内皮素-1(ET-1)、降钙素基 因相关肽(CGRP)、多巴胺(DA)、一氧化氮(NO) 水平的变化。结果:治疗后,2 组头痛发作频率、头痛平 均持续时间、VAS 评分、中医证候积分均较治疗前下降(P<0.05),试验组上述4 项指标值均低于对照 组(P<0.05)。试验组临床疗效总有效率为84.31%,对照组总有效率为67.31%,2 组比较,差异有统计学意 义(P<0.05)。试验组不良反应发生率为3.92%,对照组为13.46%,2 组比较,差异有统计学意义(P< 0.05)。试验组复发率为9.76%,对照组复发率为45.71%,2 组比较,差异有统计学意义(P<0.05)。治疗后, 2 组5-HT、CGRP、DA 水平均较治疗前上升,ET-1、NO 水平均较治疗前下降,差异均有统计学意义(P< 0.05);治疗后,试验组5-HT、CGRP、DA 水平均高于对照组,ET-1、NO 水平均低于对照组,差异均有统计 学意义(P<0.05)。结论:针刺联合散偏汤治疗偏头痛疗效确切,能改善患者头痛发作频率及持续时间,减轻 疼痛程度,提高远期疗效,安全性较高。

    Abstract:

    Abstract:Objective:To observe the clinical effect of acupuncture combined with Sanpian Decoction for migraine. Methods: A total of 108 cases of patients with migraine were selected as the research objects, and divided into the control group and the trial group according to the random number table method, with 54 cases in each group. With two cases in the control group and three cases in the experiment group dropped out,52 cases in the control group and 51 cases in the trial group were finally included. The control group was treated with Flunarizine Tablets, and the trial group was treated with acupuncture combined with Sanpian Decoction. Both groups were treated for four weeks. The clinical effects and the incidence of adverse reactions in the two groups were observed;the recurrence rates were compared between the two groups; the changes in seizure frequency and mean duration of headache, Visual Analogue Scale(VAS) of pain, traditional Chinese medicine(TCM) syndrome scores, levels of 5- hydroxytryptamine(5- HT), endothelin- 1(ET- 1), calcitonin gene- related peptide(CGRP), dopamine(DA) and nitric oxide(NO) in serum before and after treatment were compared between the two groups. Results:After treatment,the seizure frequency and mean duration of headache,VAS scores and TCM syndrome scores in the two groups were decreased when compared with those before treatment(P< 0.05), and the above four indexes in the trial group were lower than those in the control group(P<0.05). The total effective rate of clinical effect was 84.31% in the trial group and 67.31% in the control group,the difference being significant(P<0.05). The incidence of adverse reactions was 3.92% in the trial group and 13.46% in the control group,the difference being significant(P<0.05). The recurrence rate was 9.76% in the trial group and 45.71% in the control group,the difference being significant(P<0.05). After treatment, the levels of 5- HT, CGRP and DA in the two groups were increased when compared with those before treatment,and the levels of ET- 1 and NO were decreased,differences being significant(P<0.05). After treatment, the levels of 5- HT, CGRP and DA in the trial group were higher than those in the control group, and the levels of ET- 1 and NO were lower, differences being significant(P<0.05). Conclusion: The therapy of acupuncture combined with Sanpian Decoction for migraine has a definite curative effect, which can improve the seizure frequency and duration of headache,reduce the degree of pain and enhance the long-term curative effect,with high safety.

    参考文献
    相似文献
    引证文献
引用本文

顾闳邴,张萍萍,赵钰琦,许嘉隆,陈金丹.针刺联合散偏汤治疗偏头痛临床研究[J].新中医,2023,55(1):169-173

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-01-17
  • 出版日期: